Geschatte realtime
Cboe BZX
18:51:21 06-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
24,69
USD
|
+1,02%
|
|
+7,37%
|
-18,84%
|
Fiscaal tijdperk: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
2.686
|
4.405
|
6.509
|
3.498
|
2.880
|
3.028
|
-
|
-
|
Bedrijfswaarde
1 |
2.686
|
4.089
|
6.141
|
3.390
|
2.769
|
2.602
|
2.715
|
2.789
|
K/w-verhouding
|
40,8
x
|
-51,3
x
|
-45,9
x
|
-19,8
x
|
-14
x
|
-8,9
x
|
-9,52
x
|
-10,2
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
15,9
x
|
50,1
x
|
47,1
x
|
14,4
x
|
12
x
|
24,1
x
|
16,9
x
|
11,4
x
|
Bedrijfswaarde/omzet
|
15,9
x
|
46,5
x
|
44,4
x
|
13,9
x
|
11,5
x
|
20,7
x
|
15,1
x
|
10,5
x
|
Bedrijfswaarde/EBITDA
|
-
|
-46,9
x
|
-43,6
x
|
-20,2
x
|
-14,4
x
|
-7,96
x
|
-7,26
x
|
-7,51
x
|
Bedrijfswaarde/FCF
|
16,7
x
|
-38,1
x
|
41,6
x
|
-17,9
x
|
-8,38
x
|
-5,4
x
|
-9,73
x
|
-9,48
x
|
FCF Yield
|
6%
|
-2,63%
|
2,4%
|
-5,57%
|
-11,9%
|
-18,5%
|
-10,3%
|
-10,6%
|
Price to Book
|
-
|
-
|
15,9
x
|
8,79
x
|
10,6
x
|
7,45
x
|
10,6
x
|
15,8
x
|
Aantal aandelen (in duizenden)
|
95.301
|
102.292
|
104.259
|
105.849
|
107.193
|
123.897
|
-
|
-
|
Referentieprijs
2 |
28,18
|
43,06
|
62,43
|
33,05
|
26,87
|
24,44
|
24,44
|
24,44
|
Datum van publicatie
|
25/11/19
|
23/11/20
|
22/11/21
|
28/11/22
|
29/11/23
|
-
|
-
|
-
|
Fiscaal tijdperk: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
168,8
|
87,99
|
138,3
|
243,2
|
240,7
|
125,7
|
179,4
|
266,4
|
EBITDA
1 |
-
|
-87,22
|
-140,8
|
-168,1
|
-192,5
|
-326,7
|
-373,9
|
-371,2
|
Bedrijfsresultaat (EBIT)
1 |
61,19
|
-93,16
|
-149
|
-178,5
|
-205
|
-330,7
|
-331,6
|
-295,6
|
Operationele Marge
|
36,25%
|
-105,87%
|
-107,77%
|
-73,39%
|
-85,16%
|
-263,1%
|
-184,84%
|
-110,95%
|
Resultaat voor belastingen (EBT)
1 |
61,19
|
-84,55
|
-140,8
|
-172,7
|
-206,5
|
-340,9
|
-330
|
-317,1
|
Nettowinst (verlies)
1 |
67,97
|
-84,55
|
-140,8
|
-176,1
|
-205,3
|
-312,5
|
-303,7
|
-317,2
|
Nettomarge
|
40,27%
|
-96,09%
|
-101,85%
|
-72,39%
|
-85,27%
|
-248,65%
|
-169,28%
|
-119,08%
|
WPA
2 |
0,6900
|
-0,8400
|
-1,360
|
-1,670
|
-1,920
|
-2,746
|
-2,567
|
-2,397
|
Free Cash Flow
1 |
161
|
-107,3
|
147,7
|
-188,9
|
-330,6
|
-481,8
|
-279
|
-294,2
|
FCF-marge
|
95,4%
|
-121,99%
|
106,78%
|
-77,67%
|
-137,34%
|
-383,34%
|
-155,55%
|
-110,46%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
236,9%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
25/11/19
|
23/11/20
|
22/11/21
|
28/11/22
|
29/11/23
|
-
|
-
|
-
|
Fiscaal tijdperk: September |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
38,28
|
27,44
|
151,8
|
32,41
|
31,58
|
62,55
|
146,3
|
15,82
|
16,1
|
3,551
|
56,83
|
27,26
|
35,14
|
25,53
|
26,33
|
EBITDA
1 |
-62,38
|
-60,75
|
44,15
|
-70,32
|
-81,17
|
-39,44
|
50,83
|
-99,43
|
-104,5
|
-132,3
|
-86,91
|
-81,15
|
-76,07
|
-115,9
|
-116,5
|
Bedrijfsresultaat (EBIT)
1 |
-64,88
|
-63,32
|
41,55
|
-72,91
|
-83,83
|
-42,13
|
48,16
|
-102,7
|
-108,3
|
-136,5
|
-42,33
|
-77,41
|
-77,47
|
-90,35
|
-95,4
|
Operationele Marge
|
-169,48%
|
-230,77%
|
27,37%
|
-224,94%
|
-265,49%
|
-67,36%
|
32,93%
|
-648,99%
|
-672,98%
|
-3.845,25%
|
-74,48%
|
-284%
|
-220,47%
|
-353,91%
|
-362,32%
|
Resultaat voor belastingen (EBT)
1 |
-63,37
|
-62,87
|
44,37
|
-72,05
|
-82,16
|
-41,79
|
47,68
|
-103,4
|
-109
|
-138,7
|
-38,44
|
-81,72
|
-80,3
|
-114,7
|
-121,5
|
Nettowinst (verlies)
1 |
-63,37
|
-62,87
|
44,37
|
-72,05
|
-85,51
|
-41,81
|
47,68
|
-102,9
|
-109,7
|
-132,9
|
-15,55
|
-72,27
|
-69,2
|
-114,7
|
-121,5
|
Nettomarge
|
-165,54%
|
-229,13%
|
29,23%
|
-222,28%
|
-270,82%
|
-66,85%
|
32,6%
|
-650,53%
|
-681,36%
|
-3.741,59%
|
-27,37%
|
-265,14%
|
-196,92%
|
-449,18%
|
-461,55%
|
WPA
2 |
-0,6100
|
-0,6000
|
0,4100
|
-0,6800
|
-0,8100
|
-0,3900
|
0,4500
|
-0,9600
|
-1,020
|
-1,240
|
-0,2174
|
-0,6311
|
-0,5589
|
-0,8418
|
-0,8833
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
22/11/21
|
2/02/22
|
10/05/22
|
4/08/22
|
28/11/22
|
6/02/23
|
2/05/23
|
7/08/23
|
29/11/23
|
6/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
-
|
315
|
368
|
108
|
111
|
426
|
313
|
239
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
161
|
-107
|
148
|
-189
|
-331
|
-482
|
-279
|
-294
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-14,6%
|
-43,6%
|
-61,3%
|
-77,5%
|
-99,8%
|
-144%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
2 |
-
|
-
|
3,920
|
3,760
|
2,530
|
3,280
|
2,300
|
1,550
|
Cashflow per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-1,700
|
-
|
-
|
Capex
1 |
12
|
12
|
23,6
|
52,8
|
177
|
143
|
11,3
|
12
|
Capex/omzet
|
7,11%
|
13,58%
|
17,04%
|
21,7%
|
73,42%
|
113,66%
|
6,29%
|
4,52%
|
Datum van publicatie
|
25/11/19
|
23/11/20
|
22/11/21
|
28/11/22
|
29/11/23
|
-
|
-
|
-
|
Laatste slotkoers
24,44
USD Gemiddelde koersdoel
55,15
USD Spread / Gemiddelde doel +125,67% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -18,84% | 3,03 mld. | | +8,49% | 105 mld. | | -1,18% | 104 mld. | | +5,79% | 22,94 mld. | | -12,66% | 22,34 mld. | | -7,01% | 19,25 mld. | | -37,08% | 17,08 mld. | | -9,43% | 16,96 mld. | | +8,05% | 14,16 mld. | | +38,95% | 12,63 mld. |
Biotherapeutische geneesmiddelen
|